Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Venous Thrombosis

  Free Subscription


Articles published in Thromb Res

Retrieve available abstracts of 178 articles:
HTML format
Text format



Single Articles


    May 2017
  1. REZANIA S, Puskarich MA, Petrusca DN, Neto-Neves EM, et al
    Platelet hyperactivation, apoptosis and hypercoagulability in patients with acute pulmonary embolism.
    Thromb Res. 2017;155:106-115.
    PubMed     Text format     Abstract available


  2. ROY PM, Moumneh T, Penaloza A, Sanchez O, et al
    Outpatient management of pulmonary embolism.
    Thromb Res. 2017;155:92-100.
    PubMed     Text format     Abstract available


    April 2017
  3. ROBIN P, Le Roux PY, Le Moigne E, Planquette B, et al
    Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
    Thromb Res. 2017;155:6-9.
    PubMed     Text format     Abstract available


  4. DITTMAR M, Smith N, Warren B, Clark B, et al
    Improved sensitivity and specificity of pediatric hospital-acquired venous thromboembolism case identification by addition of radiographic and pharmacologic elements.
    Thromb Res. 2017;154:93-95.
    PubMed     Text format    


  5. LANGE N, Stalder O, Aujesky D
    Is clinical pre-test probability assessment for venous thromboembolism underused?
    Thromb Res. 2017;155:10-11.
    PubMed     Text format    


  6. KEVANE B, Ainle FN
    Contraception and menstrual bleeding during venous thromboembolism treatment: Does current practice reflect expert option?
    Thromb Res. 2017 Apr 12. pii: S0049-3848(17)30281.
    PubMed     Text format    


  7. CHU JN, Maselli J, Auerbach AD, Fang MC, et al
    The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
    Thromb Res. 2017;155:65-71.
    PubMed     Text format     Abstract available


  8. SQUIZZATO A, Pomero F, Allione A, Priotto R, et al
    Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis.
    Thromb Res. 2017;154:64-72.
    PubMed     Text format     Abstract available


    March 2017
  9. GON Y, Sakaguchi M, Takasugi J, Mochizuki H, et al
    Ischemic stroke in cancer patients treated with direct oral anticoagulants for venous thromboembolism.
    Thromb Res. 2017;154:16-18.
    PubMed     Text format     Abstract available


  10. KLOK FA, Schreiber K, Stach K, Ageno W, et al
    Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey.
    Thromb Res. 2017;153:101-107.
    PubMed     Text format     Abstract available


  11. BRUNSON A, Ho G, White R, Wun T, et al
    Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: A population-based study.
    Thromb Res. 2017;153:57-64.
    PubMed     Text format     Abstract available


  12. BEYAN C, Beyan E
    Mean platelet volume may not be an alternative test instead of platelet aggregation in patients with venous thromboembolism.
    Thromb Res. 2017;153:50.
    PubMed     Text format    


  13. MA K, Kahn SR, Hirsch AM, Akaberi A, et al
    N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE study.
    Thromb Res. 2017;153:47-49.
    PubMed     Text format    


  14. RUHLE F, Stoll M
    Genetic factors in pediatric venous thromboembolism.
    Thromb Res. 2017;151 Suppl 1:S97-S99.
    PubMed     Text format     Abstract available


  15. BARCO S, Konstantinides SV
    Risk-adapted management of pulmonary embolism.
    Thromb Res. 2017;151 Suppl 1:S92-S96.
    PubMed     Text format     Abstract available


  16. TROMEUR C, van der Pol LM, Klok FA, Couturaud F, et al
    Pitfalls in the diagnostic management of pulmonary embolism in pregnancy.
    Thromb Res. 2017;151 Suppl 1:S86-S91.
    PubMed     Text format     Abstract available


  17. BLANCO-MOLINA A, Trujillo-Santos J, Pesavento R, Rosa V, et al
    Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
    Thromb Res. 2017;151 Suppl 1:S6-S10.
    PubMed     Text format     Abstract available


  18. MARTIN-MARTOS F, Trujillo-Santos J, Del Toro J, Bura-Riviere A, et al
    Gender differences in patients with venous thromboembolism and five common sites of cancer.
    Thromb Res. 2017;151 Suppl 1:S16-S20.
    PubMed     Text format     Abstract available


  19. TZORAN I, Papadakis E, Brenner B, Valle R, et al
    Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
    Thromb Res. 2017;151 Suppl 1:S11-S15.
    PubMed     Text format     Abstract available


  20. MOUSTAFA F, Fernandez S, Fernandez-Capitan C, Nieto JA, et al
    Uterine bleeding during anticoagulation in women with venous thromboembolism.
    Thromb Res. 2017;151 Suppl 1:S1-S5.
    PubMed     Text format     Abstract available


    February 2017
  21. VAN ES N, Wells PS, Carrier M
    Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores.
    Thromb Res. 2017;152:52-60.
    PubMed     Text format     Abstract available


  22. WILTS IT, Le Gal G, Den Exter PL, Van Es J, et al
    Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism.
    Thromb Res. 2017;152:49-51.
    PubMed     Text format     Abstract available


  23. THEBERGE I, Bowdridge J, Forgie MA, Carrier M, et al
    Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease.
    Thromb Res. 2017;152:4-6.
    PubMed     Text format    


  24. NOJIMA J, Motoki Y, Hara K, Sakata T, et al
    Detection of antibodies against domain 1 of beta2-glycoprotein I is key in predicting thromboembolic complications in patients with systemic lupus erythematosus.
    Thromb Res. 2017;153:83-84.
    PubMed     Text format    


    January 2017
  25. KHORANA AA, Francis CW, Kuderer NM, Carrier M, et al
    Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
    Thromb Res. 2017 Jan 26. pii: S0049-3848(17)30020.
    PubMed     Text format     Abstract available


  26. PUURUNEN MK, Hwang SJ, O'Donnell CJ, Tofler G, et al
    Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study.
    Thromb Res. 2017;151:57-62.
    PubMed     Text format     Abstract available


  27. COWAN LT, Lutsey PL, Pankow JS, Cushman M, et al
    Hospitalization with infection and incident venous thromboembolism: The ARIC study.
    Thromb Res. 2017;151:74-78.
    PubMed     Text format     Abstract available


  28. COYLE K, Carrier M, Lazo-Langner A, Shivakumar S, et al
    Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
    Thromb Res. 2017;151:67-71.
    PubMed     Text format     Abstract available


  29. KUO TH, Li HY, Lin SH
    Acute kidney injury and risk of deep vein thrombosis and pulmonary embolism in Taiwan: A nationwide retrospective cohort study.
    Thromb Res. 2017;151:29-35.
    PubMed     Text format     Abstract available


  30. ENDE-VERHAAR YM, Huisman MV, Klok FA
    To screen or not to screen for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.
    Thromb Res. 2017;151:1-7.
    PubMed     Text format     Abstract available


    December 2016
  31. ZOLLER B, Li X, Ohlsson H, Sundquist J, et al
    Seasonal variation of pulmonary embolism and age dependence.
    Thromb Res. 2016;150:76-77.
    PubMed     Text format    


  32. ROSS JA, Miller MM, Rojas Hernandez CM
    Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
    Thromb Res. 2016;150:86-89.
    PubMed     Text format     Abstract available


  33. VAN ES N, Franke VF, Middeldorp S, Wilmink JW, et al
    The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer.
    Thromb Res. 2016;150:30-32.
    PubMed     Text format     Abstract available


  34. SWIER N, Versteeg HH
    Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression.
    Thromb Res. 2016;150:8-18.
    PubMed     Text format     Abstract available


  35. OZCAN CETIN EH, Cetin MS, Canpolat U, Akdi A, et al
    Platelet-to-lymphocyte ratio as a novel marker of in-hospital and long-term adverse outcomes among patients with acute pulmonary embolism: A single center large-scale study.
    Thromb Res. 2016;150:33-40.
    PubMed     Text format     Abstract available


  36. PIOVELLA F, Iosub DI
    Extended non-vitamin K antagonist oral anticoagulation therapy for prevention of recurrent venous thromboembolism.
    Thromb Res. 2016 Dec 7. pii: S0049-3848(16)30645.
    PubMed     Text format     Abstract available


  37. GARCIA-HORTON A, Kovacs MJ, Abdulrehman J, Taylor JE, et al
    Impact of thrombophilia screening on venous thromboembolism management practices.
    Thromb Res. 2016;149:76-80.
    PubMed     Text format     Abstract available


    November 2016
  38. OLIE V, Bonaldi C
    Pulmonary embolism: Does the seasonal effect depend on age? A 12-year nationwide analysis of hospitalization and mortality.
    Thromb Res. 2016 Nov 30. pii: S0049-3848(16)30640.
    PubMed     Text format     Abstract available


  39. LIN CL, Lin CL, Tzeng SL, Chung WS, et al
    Aplastic anemia and risk of deep vein thrombosis and pulmonary embolism: A nationwide cohort study.
    Thromb Res. 2016;149:70-75.
    PubMed     Text format     Abstract available


  40. BURWEN DR, Wu C, Cirillo D, Rossouw JE, et al
    Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claims.
    Thromb Res. 2016;150:78-85.
    PubMed     Text format     Abstract available


    October 2016
  41. PLANQUETTE B, Ferre A, Peron J, Vial-Dupuy A, et al
    Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
    Thromb Res. 2016;148:70-75.
    PubMed     Text format     Abstract available


  42. ALEXANDER M, Burbury K
    A systematic review of biomarkers for the prediction of thromboembolism in lung cancer - Results, practical issues and proposed strategies for future risk prediction models.
    Thromb Res. 2016;148:63-69.
    PubMed     Text format     Abstract available


  43. BEYER-WESTENDORF J
    Letter to the Editor "Gender related aspects of bleeding with rivaroxaban in venous thromboembolism - Potential for pitfalls": A comment to "Impact of gender on safety and efficacy of rivaroxaban in adolescents & young adults with venous thromboem
    Thromb Res. 2016 Oct 26. pii: S0049-3848(16)30601.
    PubMed     Text format    


  44. ZOLLER B, Ohlsson H, Sundquist J, Sundquist K, et al
    A sibling based design to quantify genetic and shared environmental effects of venous thromboembolism in Sweden.
    Thromb Res. 2016 Oct 20. pii: S0049-3848(16)30587.
    PubMed     Text format     Abstract available


  45. KANG J, Lee JS, Lee JH, Lee KM, et al
    Recurrent pulmonary embolism during dabigatran treatment in a patient with immune thrombocytopenic purpura.
    Thromb Res. 2016;148:23-24.
    PubMed     Text format    


  46. MELANCON T, Bivona C, Klenke S, Rockey M, et al
    Comparison of postoperative venous thromboembolism incidence in gastrointestinal and gynecologic solid tumors.
    Thromb Res. 2016;147:104-107.
    PubMed     Text format     Abstract available


  47. RABINOVICH E, Bartholomew JR, Wilks ML, Tripp BL, et al
    Centralizing care of cancer-associated thromboembolism: The Cleveland Clinic experience.
    Thromb Res. 2016;147:102-103.
    PubMed     Text format    


  48. PIRAN S, Schulman S
    Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study.
    Thromb Res. 2016;147:97-101.
    PubMed     Text format     Abstract available


    September 2016
  49. CORRAINI P, Ording AG, Henderson VW, Szepligeti S, et al
    Cancer, other comorbidity, and risk of venous thromboembolism after stroke: a population-based cohort study.
    Thromb Res. 2016;147:88-93.
    PubMed     Text format     Abstract available


  50. VINSON DR, Ballard DW, Mark DG, Huang J, et al
    Risk stratifying emergency department patients with acute pulmonary embolism: Does the simplified Pulmonary Embolism Severity Index perform as well as the original?
    Thromb Res. 2016;148:1-8.
    PubMed     Text format     Abstract available


  51. DEMELO-RODRIGUEZ P, Postigo-Esteban A, Garcia-Fernandez-Bravo I, Agud M, et al
    Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists.
    Thromb Res. 2016;147:58-60.
    PubMed     Text format     Abstract available


  52. VOILS SA, Lemon SJ, Jordan J, Riley P, et al
    Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
    Thromb Res. 2016;147:13-15.
    PubMed     Text format     Abstract available


  53. BLEKER SM, Beenen LF, Di Nisio M, van Es N, et al
    Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots.
    Thromb Res. 2016;147:46-51.
    PubMed     Text format     Abstract available


  54. ARACHCHILLAGE D, Reynolds R, Devey T, Maclean R, et al
    Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
    Thromb Res. 2016;147:32-35.
    PubMed     Text format    


  55. KRAUSE M, Henningsen A, Torge A, Juhl D, et al
    Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
    Thromb Res. 2016 Sep 13. pii: S0049-3848(16)30542.
    PubMed     Text format    


    August 2016
  56. PETCH S, Norris L, O'Toole S, Gleeson N, et al
    Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practice.
    Thromb Res. 2016;145:126-128.
    PubMed     Text format    


    July 2016
  57. GROSSE SD
    Cost-of-illness models for venous thromboembolism: One size does not fit all.
    Thromb Res. 2016;145:65-66.
    PubMed     Text format    


  58. HOFMANN E, Limacher A, Mean M, Kucher N, et al
    Echocardiography does not predict mortality in hemodynamically stable elderly patients with acute pulmonary embolism.
    Thromb Res. 2016;145:67-71.
    PubMed     Text format     Abstract available


  59. KHORANA AA, Yannicelli D, McCrae KR, Milentijevic D, et al
    Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
    Thromb Res. 2016;145:51-53.
    PubMed     Text format     Abstract available


  60. PUURUNEN MK, Enserro D, Xanthakis V, Larson MG, et al
    Biomarkers for the prediction of venous thromboembolism in the community.
    Thromb Res. 2016;145:34-39.
    PubMed     Text format     Abstract available


    June 2016
  61. PUURUNEN MK, Gona PN, Larson MG, Murabito JM, et al
    Epidemiology of venous thromboembolism in the Framingham Heart Study.
    Thromb Res. 2016;145:27-33.
    PubMed     Text format     Abstract available


  62. MAHAN CE, Barco S, Spyropoulos AC
    Cost-of-illness model for venous thromboembolism.
    Thromb Res. 2016 Jun 23. pii: S0049-3848(16)30460.
    PubMed     Text format    


  63. KUBOTA Y, McAdams-DeMarco M, Folsom AR
    Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study.
    Thromb Res. 2016;144:144-148.
    PubMed     Text format     Abstract available


  64. ROUZAUD D, Alexandra JF, Chauchard M, Delon M, et al
    Incidental venous thromboembolism diagnosed in patients admitted with a first venous thromboembolism: Frequency and clinical significance (an observational study).
    Thromb Res. 2016;144:116-118.
    PubMed     Text format    


  65. CUSHMAN M, O'Meara ES, Heckbert SR, Zakai NA, et al
    Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology.
    Thromb Res. 2016;144:127-132.
    PubMed     Text format     Abstract available


  66. BLEKER SM, Buchmuller A, Chauleur C, Ainle FN, et al
    Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
    Thromb Res. 2016;144:62-68.
    PubMed     Text format     Abstract available


  67. AMBRUS DB, Reisman JI, Rose AJ
    The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism.
    Thromb Res. 2016;144:21-26.
    PubMed     Text format     Abstract available


    May 2016
  68. BAUERSACHS R
    Non-vitamin K antagonist oral anticoagulants for the prevention of recurrent venous thromboembolism.
    Thromb Res. 2016;144:12-20.
    PubMed     Text format     Abstract available


  69. GARCIA-OLIVARES P, Guerrero JE, Keough E, Galdos P, et al
    Clinical factors associated with inappropriate prophylaxis of venous thromboembolic disease in critically ill patients. A single day cross-sectional study.
    Thromb Res. 2016;143:111-117.
    PubMed     Text format     Abstract available


  70. CARMONA-BAYONAS A, Font C, Jimenez-Fonseca P, Fenoy F, et al
    On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism.
    Thromb Res. 2016;143:76-85.
    PubMed     Text format     Abstract available


  71. BARNES GD, Izzo B, Conte ML, Chopra V, et al
    Use of decision aids for shared decision making in venous thromboembolism: A systematic review.
    Thromb Res. 2016;143:71-75.
    PubMed     Text format     Abstract available


  72. SANFILIPPO KM, Wang TF, Gage BF, Luo S, et al
    Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.
    Thromb Res. 2016;143:86-90.
    PubMed     Text format     Abstract available


  73. NICKEL KF, Labberton L, Long AT, Langer F, et al
    The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies.
    Thromb Res. 2016;141 Suppl 2:S4-7.
    PubMed     Text format     Abstract available


  74. GAUTHIER K, Le Gal G, Shivakumar S, Anderson D, et al
    Inter-observer reliability of the HERDOO2 clinical decision rule.
    Thromb Res. 2016;141:136-8.
    PubMed     Text format    


    April 2016
  75. RODGER MA, Phillips P, Kahn SR, Bates S, et al
    Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial.
    Thromb Res. 2016;142:17-20.
    PubMed     Text format    


  76. KRISTOFFERSEN AH, Ajzner E, Rogic D, Sozmen EY, et al
    Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries.
    Thromb Res. 2016;142:1-7.
    PubMed     Text format     Abstract available


  77. MENAPACE LA, McCrae KR, Khorana AA
    Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.
    Thromb Res. 2016;140 Suppl 1:S93-8.
    PubMed     Text format     Abstract available


  78. GHESHMY A, Carrier M
    Venous thromboembolism and occult cancer: impact on clinical practice.
    Thromb Res. 2016;140 Suppl 1:S8-S11.
    PubMed     Text format     Abstract available


  79. LIEBMAN HA, O'Connell C
    Incidental venous thromboembolic events in cancer patients: what we know in 2016.
    Thromb Res. 2016;140 Suppl 1:S18-20.
    PubMed     Text format     Abstract available


  80. BRUNSON A, Ho G, White R, Wun T, et al
    Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes.
    Thromb Res. 2016;140 Suppl 1:S132-41.
    PubMed     Text format     Abstract available


  81. ROMUALDI E, Ageno W
    Management of recurrent venous thromboembolism in cancer patients.
    Thromb Res. 2016;140 Suppl 1:S128-31.
    PubMed     Text format     Abstract available


  82. RIEDL J, Kaider A, Marosi C, Prager G, et al
    PO-63 - Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis.
    Thromb Res. 2016;140 Suppl 1:S199-200.
    PubMed     Text format     Abstract available


  83. WELLS PS, Theberge IA, Bowdridge JC, Forgie MA, et al
    PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease.
    Thromb Res. 2016;140 Suppl 1:S191-2.
    PubMed     Text format     Abstract available


  84. MANCUSO A, Vedovati MC, Pierpaoli L, Paliani U, et al
    PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort.
    Thromb Res. 2016;140 Suppl 1:S191.
    PubMed     Text format     Abstract available


  85. WILTS IT, Le Gal G, den Exter PL, van Es J, et al
    PO-29 - Age-adjusted D-dimer cutoff level increases the number of cancer patients in who pulmonary embolism can be safely excluded without CT-PA imaging: The ADJUST-PE cancer substudy.
    Thromb Res. 2016;140 Suppl 1:S187.
    PubMed     Text format     Abstract available


  86. VAN ES N, van der Hulle T, van Es J, den Exter PL, et al
    PO-07 - Excluding pulmonary embolism in cancer patients using the Wells rule and age-adjusted D-dimer testing: an individual patient data meta-analysis.
    Thromb Res. 2016;140 Suppl 1:S179.
    PubMed     Text format     Abstract available


  87. CORRAINI P, Ording AG, Henderson VW, Szepligeti S, et al
    PO-06 - Cancer and the risk of venous thromboembolism in stroke patients.
    Thromb Res. 2016;140 Suppl 1:S178.
    PubMed     Text format     Abstract available


  88. ADRIAN SG, de Castro EM, Olmos VP, Martin MN, et al
    PO-05 - Incidence of venous thromboembolism (VTE) in bile duct tumors (BDT) treated with chemotherapy in ambulatory setting.
    Thromb Res. 2016;140 Suppl 1:S178.
    PubMed     Text format     Abstract available


  89. SANTI RM, Ceccarelli M, Catania G, Monagheddu C, et al
    PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).
    Thromb Res. 2016;140 Suppl 1:S177.
    PubMed     Text format     Abstract available


  90. MARTIN AJ, Ziyatdinov A, Rubio VC, Olmos VP, et al
    PO-04 - A new genetic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy.
    Thromb Res. 2016;140 Suppl 1:S177-8.
    PubMed     Text format     Abstract available


  91. KONIGSBRUGGE O, Riedl J, Grilz E, Wiltschke C, et al
    PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patients.
    Thromb Res. 2016;140 Suppl 1:S176.
    PubMed     Text format     Abstract available


  92. PIATEK CI, Tagawa ST, Wei-Tsai D, Hanna D, et al
    OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin.
    Thromb Res. 2016;140 Suppl 1:S174.
    PubMed     Text format     Abstract available


  93. COSMI B, Legnani C, Ghirarduzzi A, De Micheli V, et al
    OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism.
    Thromb Res. 2016;140 Suppl 1:S174.
    PubMed     Text format     Abstract available


  94. ROSS JA, Miller M, Hernandez CR
    OC-13 - Safe and effective use of direct oral anticoagulants (DOAC) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism.
    Thromb Res. 2016;140 Suppl 1:S173-4.
    PubMed     Text format     Abstract available


  95. PETCH S, Norris LA, O'Toole SA, Gleeson N, et al
    OC-12 - Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practice.
    Thromb Res. 2016;140 Suppl 1:S173.
    PubMed     Text format     Abstract available


  96. YOUNG A, Phillips J, Hancocks H, Hill C, et al
    OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.
    Thromb Res. 2016;140 Suppl 1:S172-3.
    PubMed     Text format     Abstract available


  97. ANTIC D, Milic N, Todorovic M, Bila J, et al
    OC-07 - Decoding risk for thromboembolic events in lymphoma patients.
    Thromb Res. 2016;140 Suppl 1:S171.
    PubMed     Text format     Abstract available


  98. ALEXANDER M, Wolfe R, Ball D, Manser R, et al
    OC-05 - D-Dimer, fibrinogen and TEG-MA predict thromboembolism in non-small cell lung cancer - interim results from a prospective cohort study.
    Thromb Res. 2016;140 Suppl 1:S170.
    PubMed     Text format     Abstract available


  99. NAVI BB, Reiner AS, Kamel H, Iadecola C, et al
    OC-02 - Risk of arterial thromboembolism in patients with breast cancer.
    Thromb Res. 2016;140 Suppl 1:S169.
    PubMed     Text format     Abstract available


    March 2016
  100. PARK MS, Perkins SE, Spears GM, Ashrani AA, et al
    Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study.
    Thromb Res. 2016;144:40-45.
    PubMed     Text format     Abstract available


  101. MARTINELLI I, Maino A, Abbattista M, Bucciarelli P, et al
    Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study.
    Thromb Res. 2016;141:153-157.
    PubMed     Text format     Abstract available


  102. ISHOLA T, Kirk SE, Guffey D, Voigt K, et al
    Risk factors and co-morbidities in adolescent thromboembolism are different than those in younger children.
    Thromb Res. 2016;141:178-182.
    PubMed     Text format     Abstract available


  103. SAMUELSON BT, Gernsheimer T, Estey E, Garcia DA, et al
    Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia.
    Thromb Res. 2016;141:104-105.
    PubMed     Text format    


  104. RATASVUORI M, Lassila R, Laitinen M
    Venous thromboembolism after surgical treatment of non-spinal skeletal metastases - An underdiagnosed complication.
    Thromb Res. 2016;141:124-128.
    PubMed     Text format     Abstract available


  105. PRANDONI P, Noventa F, Lensing AW, Prins MH, et al
    Post-thrombotic syndrome and the risk of subsequent recurrent thromboembolism.
    Thromb Res. 2016;141:91-92.
    PubMed     Text format    


  106. YU TT, Nelson J, Streiff MB, Lanzkron S, et al
    Risk factors for venous thromboembolism in adults with hemoglobin SC or Sbeta thalassemia genotypes.
    Thromb Res. 2016;141:35-38.
    PubMed     Text format     Abstract available


  107. BORGDORFF P, Tangelder GJ
    Arguments favoring low versus high dose aspirin in the prophylaxis of venous thromboembolism.
    Thromb Res. 2016;139:121-4.
    PubMed     Text format    


  108. FOLSOM AR, Tang W, George KM, Heckbert SR, et al
    Prospective study of gamma' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Thromb Res. 2016;139:44-9.
    PubMed     Text format     Abstract available


  109. ASHRANI AA, Gullerud RE, Petterson TM, Marks RS, et al
    Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study.
    Thromb Res. 2016;139:29-37.
    PubMed     Text format     Abstract available


  110. BOVA C, Bianco A, Mascaro V, Nobile CG, et al
    Extended anticoagulation and mortality in venous thromboembolism. A meta-analysis of six randomized trials.
    Thromb Res. 2016;139:22-8.
    PubMed     Text format     Abstract available


  111. PRASAD M, McBane R, Reriani M, Lerman LO, et al
    Coronary endothelial dysfunction is associated with increased risk of venous thromboembolism.
    Thromb Res. 2016;139:17-21.
    PubMed     Text format     Abstract available


    February 2016
  112. LABRADOR J, Gonzalez-Rivero J, Monroy R, Lozano FS, et al
    Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center.
    Thromb Res. 2016 Feb 18. pii: S0049-3848(16)30043.
    PubMed     Text format     Abstract available


  113. ROZJABEK HM, Coleman CI, Weeda ER, Peacock WF, et al
    Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination.
    Thromb Res. 2016;141:8-10.
    PubMed     Text format    


  114. SNEEBOER MM, Hutten BA, Majoor CJ, Bel EH, et al
    Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism.
    Thromb Res. 2016;140:46-50.
    PubMed     Text format     Abstract available


  115. LJUNGQVIST M, Holmstrom M, Kieler H, Odeberg J, et al
    Cardiovascular disease and mortality after a first episode of venous thromboembolism in young and middle-aged women.
    Thromb Res. 2016;138:80-5.
    PubMed     Text format     Abstract available


  116. JORGENSEN CC, Kehlet H
    Early thromboembolic events </=1week after fast-track total hip and knee arthroplasty.
    Thromb Res. 2016;138:37-42.
    PubMed     Text format     Abstract available


  117. OLIVIER CB, Weik P, Meyer M, Weber S, et al
    TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
    Thromb Res. 2016;138:63-8.
    PubMed     Text format     Abstract available


    December 2015
  118. ZHOU X, Wen W, Shan X, Qian J, et al
    MiR-28-3p as a potential plasma marker in diagnosis of pulmonary embolism.
    Thromb Res. 2015 Dec 10. pii: S0049-3848(15)30219.
    PubMed     Text format     Abstract available


  119. WANG CY, Ignjatovic V, Francis P, Cain T, et al
    Risk factors and clinical features of acute pulmonary embolism in children from the community.
    Thromb Res. 2015 Dec 10. pii: S0049-3848(15)30220.
    PubMed     Text format     Abstract available


  120. PEIMAN S, Abbasi M, Allameh SF, Asadi Gharabaghi M, et al
    Subsegmental pulmonary embolism: A narrative review.
    Thromb Res. 2015 Dec 8. pii: S0049-3848(15)30218.
    PubMed     Text format     Abstract available


  121. SUGIURA K, Kobayashi T, Ojima T
    Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women.
    Thromb Res. 2015 Dec 2. pii: S0049-3848(15)30216.
    PubMed     Text format     Abstract available


    November 2015
  122. CARPENTER SL, Goldman J, Sherman AK, Jeremiah Bell J, et al
    Clinical variables and Staphylococcus aureus virulence factors associated with venous thromboembolism in children.
    Thromb Res. 2015 Nov 25. pii: S0049-3848(15)30205.
    PubMed     Text format     Abstract available


  123. GROSSE SD, Nelson RE, Nyarko KA, Richardson LC, et al
    The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
    Thromb Res. 2015 Nov 24. pii: S0049-3848(15)30209.
    PubMed     Text format     Abstract available


  124. CARRUZZO P, Mean M, Limacher A, Aujesky D, et al
    Association between smoking and recurrence of venous thromboembolism and bleeding in elderly patients with past acute venous thromboembolism.
    Thromb Res. 2015 Nov 24. pii: S0049-3848(15)30210.
    PubMed     Text format     Abstract available


  125. EDWIN NC, Khoury MN, Sohal D, McCrae KR, et al
    Recurrent venous thromboembolism in glioblastoma.
    Thromb Res. 2015 Nov 22. pii: S0049-3848(15)30203.
    PubMed     Text format     Abstract available


  126. HEATH OM, van Beekhuizen HJ, Nama V, Kolomainen D, et al
    Venous thromboembolism at time of diagnosis of ovarian cancer: Survival differs in symptomatic and asymptomatic cases.
    Thromb Res. 2015 Nov 22. pii: S0049-3848(15)30206.
    PubMed     Text format     Abstract available


  127. QIAN C, Yan H, Hu X, Zhang W, et al
    Increased risk of venous thromboembolism in patients with brain tumors: A systematic review and meta-analysis.
    Thromb Res. 2015 Nov 20. pii: S0049-3848(15)30194.
    PubMed     Text format     Abstract available


  128. MASOTTI L, Verdiani V, Cei M, Cioppi A, et al
    The predictive role of the Bova risk score in acute normotensive pulmonary embolism: A retrospective analysis on a real life cohort.
    Thromb Res. 2015 Nov 20. pii: S0049-3848(15)30197.
    PubMed     Text format    


  129. BACH AG, Bandzauner R, Nansalmaa B, Schurig N, et al
    Timing of pulmonary embolism diagnosis in the emergency department.
    Thromb Res. 2015 Nov 18. pii: S0049-3848(15)30195.
    PubMed     Text format    


  130. ALVARADO-MORENO JA, Hernandez-Lopez R, Chavez-Gonzalez A, Yoder MC, et al
    Endothelial colony-forming cells: Biological and functional abnormalities in patients with recurrent, unprovoked venous thromboembolic disease.
    Thromb Res. 2015 Nov 10. pii: S0049-3848(15)30181.
    PubMed     Text format     Abstract available


  131. DELATE T, Hsiao W, Kim B, Witt DM, et al
    Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.
    Thromb Res. 2015 Nov 10. pii: S0049-3848(15)30185.
    PubMed     Text format     Abstract available


  132. MWIRIGI A, McDonald V, Shapiro S, Hunt BJ, et al
    Is there benefit in extensive screening for cancer in patients with unprovoked venous thromboembolism?
    Thromb Res. 2015 Nov 6. pii: S0049-3848(15)30174.
    PubMed     Text format    


  133. SWANEPOEL AC, Pretorius E
    Prevention and follow-up in thromboembolic ischemic stroke: Do we need to think out of the box?
    Thromb Res. 2015 Nov 4. pii: S0049-3848(15)30177.
    PubMed     Text format     Abstract available


    October 2015
  134. PORTILLO J, de la Rocha IV, Font L, Braester A, et al
    Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.
    Thromb Res. 2015 Oct 30. pii: S0049-3848(15)30175.
    PubMed     Text format     Abstract available


  135. AL-ANI F, Shariff S, Siqueira L, Seyam A, et al
    Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative data.
    Thromb Res. 2015 Oct 29. pii: S0049-3848(15)30167.
    PubMed     Text format     Abstract available


  136. PESAVENTO R, Visona A, Villalta S, Vescovo G, et al
    Residual pulmonary obstruction and the risk of late complications in patients with pulmonary embolism.
    Thromb Res. 2015 Oct 28. pii: S0049-3848(15)30165.
    PubMed     Text format    


  137. MANSFIELD AS, Tafur AJ, Vulih D, Smith GL, et al
    Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.
    Thromb Res. 2015 Oct 20. pii: S0049-3848(15)30158.
    PubMed     Text format     Abstract available


  138. OKOROH EM, Boulet SL, George MG, Craig Hooper W, et al
    Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome.
    Thromb Res. 2015 Oct 17. pii: S0049-3848(15)30154.
    PubMed     Text format     Abstract available


  139. MEYER MR, Witt DM, Delate T, Johnson SG, et al
    Thrombophilia testing patterns amongst patients with acute venous thromboembolism.
    Thromb Res. 2015 Oct 15. pii: S0049-3848(15)30151.
    PubMed     Text format     Abstract available


  140. WITT DM, Clark NP, Martinez K, Schroeder A, et al
    Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
    Thromb Res. 2015 Oct 7. pii: S0049-3848(15)30134.
    PubMed     Text format     Abstract available


    September 2015
  141. WASSEL CL, Rasmussen-Torvik LJ, Callas PW, Denenberg JO, et al
    A genetic risk score comprising known venous thromboembolism loci is associated with chronic venous disease in a multi-ethnic cohort.
    Thromb Res. 2015 Sep 26. pii: S0049-3848(15)30127.
    PubMed     Text format     Abstract available


  142. LEE SE, Jeon YW, Yoon JH, Cho BS, et al
    Clinical outcomes of venous thromboembolism with dalteparin therapy in multiple myeloma patients.
    Thromb Res. 2015 Sep 26. pii: S0049-3848(15)30132.
    PubMed     Text format     Abstract available


  143. SUGIURA K, Kobayashi T, Ojima T
    Thromboembolism as the adverse event of combined oral contraceptives in Japan.
    Thromb Res. 2015 Sep 16. pii: S0049-3848(15)30122.
    PubMed     Text format     Abstract available


  144. GAO GY, Yang P, Liu M, Ding M, et al
    Thrombolysis for acute intermediate-risk pulmonary embolism: A meta-analysis.
    Thromb Res. 2015 Sep 12. pii: S0049-3848(15)30123.
    PubMed     Text format     Abstract available


  145. VERSO M, Chiari R, Mosca S, Franco L, et al
    Incidence of Ct scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinoma.
    Thromb Res. 2015 Sep 9. pii: S0049-3848(15)30117.
    PubMed     Text format    


  146. UNGPRASERT P, Tanratana P, Srivali N
    Autoimmune hemolytic anemia and venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2015 Sep 6. pii: S0049-3848(15)30115.
    PubMed     Text format     Abstract available


  147. LUND JL, Ostgard LS, Prandoni P, Sorensen HT, et al
    Incidence, determinants and the transient impact of cancer treatments on venous thromboembolism risk among lymphoma patients in Denmark.
    Thromb Res. 2015 Sep 5. pii: S0049-3848(15)30112.
    PubMed     Text format     Abstract available


  148. SZLAUER A, Mielimonka A, Glowacki R, Borowczyk K, et al
    Protein N-linked homocysteine is associated with recurrence of venous thromboembolism.
    Thromb Res. 2015 Sep 5. pii: S0049-3848(15)30113.
    PubMed     Text format     Abstract available


  149. KELLER K, Prochaska JH, Coldewey M, Gobel S, et al
    History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism.
    Thromb Res. 2015 Sep 3. pii: S0049-3848(15)30107.
    PubMed     Text format     Abstract available


  150. SPRONK HM, Cannegieter S, Morange P, Hackeng T, et al
    Theme 2: Epidemiology, Biomarkers, and Imaging of Venous Thromboembolism (and postthrombotic syndrome).
    Thromb Res. 2015;136 Suppl 1:S8-S12.
    PubMed     Text format    


  151. VAN DER MEIJDEN PE, Ozaki Y, Ruf W, de Laat B, et al
    Theme 1: Pathogenesis of venous thromboembolism (and post-thrombotic syndrome).
    Thromb Res. 2015;136 Suppl 1:S3-7.
    PubMed     Text format    


  152. TEN CATE-HOEK AJ, Weitz JI, Gailani D, Meijer K, et al
    Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).
    Thromb Res. 2015;136 Suppl 1:S13-8.
    PubMed     Text format    


    August 2015
  153. KLINE JA, Steuerwald NM, Watts JA, Courtney M, et al
    Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.
    Thromb Res. 2015 Aug 28. pii: S0049-3848(15)30097.
    PubMed     Text format     Abstract available


  154. FOLSOM AR, Alonso A, George KM, Roetker NS, et al
    Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study.
    Thromb Res. 2015 Aug 28. pii: S0049-3848(15)30101.
    PubMed     Text format     Abstract available


  155. BIANCONI D, Schuler A, Pausz C, Geroldinger A, et al
    Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients.
    Thromb Res. 2015 Aug 28. pii: S0049-3848(15)30093.
    PubMed     Text format     Abstract available


    July 2015
  156. SINDET-PEDERSEN C, Pallisgaard JL, Olesen JB, Gislason GH, et al
    Safety and efficacy of direct oral anticoagulants compared to warfarin for extended treatment of venous thromboembolism -a systematic review and meta-analysis.
    Thromb Res. 2015 Jul 29. pii: S0049-3848(15)30073.
    PubMed     Text format     Abstract available


  157. HAN C, Zhao Y, Cheng W, Yang J, et al
    The performance of age-adjusted D-dimer cut-off in Chinese outpatients with suspected venous thromboembolism.
    Thromb Res. 2015 Jul 26. pii: S0049-3848(15)30075.
    PubMed     Text format     Abstract available


  158. BUCCIARELLI P, Maino A, Felicetta I, Abbattista M, et al
    Association between red cell distribution width and risk of venous thromboembolism.
    Thromb Res. 2015 Jul 25. pii: S0049-3848(15)30071.
    PubMed     Text format     Abstract available


  159. POSCH F, Konigsbrugge O, Zielinski C, Pabinger I, et al
    Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants.
    Thromb Res. 2015 Jul 17. pii: S0049-3848(15)30062.
    PubMed     Text format     Abstract available


  160. STARIKOVA I, Jamaly S, Sorrentino A, Blondal T, et al
    Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals.
    Thromb Res. 2015 Jul 15. pii: S0049-3848(15)30057.
    PubMed     Text format     Abstract available


  161. ZOLLER B, Palmer K, Li X, Sundquist J, et al
    Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study.
    Thromb Res. 2015 Jul 14. pii: S0049-3848(15)30056.
    PubMed     Text format     Abstract available


  162. YANG Y, Zhang XZ, Ng HS, Fong JC, et al
    The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.
    Thromb Res. 2015 Jul 6. pii: S0049-3848(15)30045.
    PubMed     Text format     Abstract available


  163. FAIZ AS, Khan I, Beckman MG, Bockenstedt P, et al
    Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism.
    Thromb Res. 2015 Jul 5. pii: S0049-3848(15)30049.
    PubMed     Text format     Abstract available


    June 2015
  164. HEIT JA, Lahr BD, Ashrani AA, Petterson TM, et al
    Predictors of Venous Thromboembolism Recurrence, Adjusted for Treatments and Interim Exposures: A Population-based Case-cohort Study.
    Thromb Res. 2015 Jun 24. pii: S0049-3848(15)30041.
    PubMed     Text format     Abstract available


  165. LINDQVIST PG, von Kanel R
    How to avoid venous thromboembolism in women at increased risk - with special focus on low-risk periods.
    Thromb Res. 2015 Jun 19. pii: S0049-3848(15)30032.
    PubMed     Text format     Abstract available


  166. DEN EXTER PL, van der Hulle T, Hartmann IJ, Jimenez D, et al
    Reliability of diagnosing incidental pulmonary embolism in cancer patients.
    Thromb Res. 2015 Jun 19. pii: S0049-3848(15)30039.
    PubMed     Text format     Abstract available


  167. MINIATI M
    Perfusion lung scintigraphy for pulmonary embolism.
    Thromb Res. 2015 Jun 4. pii: S0049-3848(15)30014.
    PubMed     Text format    


    May 2015
  168. COHEN A, Jeyaindran S, Kim JY, Park K, et al
    Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants.
    Thromb Res. 2015 May 27. pii: S0049-3848(15)30003.
    PubMed     Text format     Abstract available


  169. VAN ES J, Douma RA, Hezemans RE, Penaloza A, et al
    Accuracy of X-ray with perfusion scan in young patients with suspected pulmonary embolism.
    Thromb Res. 2015 May 21. pii: S0049-3848(15)00245.
    PubMed     Text format     Abstract available


  170. XIE J, Ma J, Kang P, Zhou Z, et al
    Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases.
    Thromb Res. 2015 May 21. pii: S0049-3848(15)00241.
    PubMed     Text format     Abstract available


  171. SIMKOVIC M, Vodarek P, Motyckova M, Belada D, et al
    Venous thromboembolism in patients with chronic lymphocytic leukemia.
    Thromb Res. 2015 May 20. pii: S0049-3848(15)00237.
    PubMed     Text format     Abstract available


  172. BAUDOUY D, Moceri P, Chiche O, Bouvier P, et al
    B blood group: A strong risk factor for venous thromboembolism recurrence.
    Thromb Res. 2015 May 8. pii: S0049-3848(15)00227.
    PubMed     Text format     Abstract available


  173. ARLIKAR SJ, Atchison CM, Amankwah EK, Ayala IA, et al
    Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery.
    Thromb Res. 2015 May 3. pii: S0049-3848(15)00208.
    PubMed     Text format     Abstract available


  174. COMEROTA AJ, Oostra C, Fayad Z, Gunning W, et al
    A histological and functional description of the tissue causing chronic postthrombotic venous obstruction.
    Thromb Res. 2015;135:882-7.
    PubMed     Text format     Abstract available


  175. KUROIWA M, Takahira N, Ujihashi Y, Miida K, et al
    Reduction in the soles of graduated compression stockings prevents falls without reducing the preventive effect for venous stasis.
    Thromb Res. 2015;135:877-81.
    PubMed     Text format     Abstract available


  176. LARSEN AC, Frokjaer JB, Fisker RV, Iyer V, et al
    Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors.
    Thromb Res. 2015;135:802-8.
    PubMed     Text format     Abstract available


    April 2015
  177. LIPPI G, Cervellin G, Mattiuzzi C
    Red meat, processed meat and the risk of venous thromboembolism: Friend or foe?
    Thromb Res. 2015 Apr 29. pii: S0049-3848(15)00199.
    PubMed     Text format     Abstract available


  178. MARVIG CL, Verhoef TI, de Boer A, Kamali F, et al
    Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants.
    Thromb Res. 2015 Apr 25. pii: S0049-3848(15)00198.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: